MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'anti cancer'. Sat, 03 Sep 2011 02:31:11 +0100 http://www.medworm.com/index.php?rid=3115048&cid=t_143337_87_f&fid=34872&url=http%3A%2F%2Fwww.blisstree.com%2Fhealthbolt%2Fanti-cancer-drugs-to-be-put-in-junk-food%2F Would you eat junk food that had anti-cancer medications? Would you buy the stuff? How expensive would it be? Wouldn’t it be easier just to not eat it in the first place or would more people start eating junk food or increase their consumption because of the anti-cancer properties? All these questions – but with good reason. Because according to news reports, Health Canada is thinking about doing just that. If this was April 1, I’d be checking for an April Fool’s joke, for sure. This was first reported on December 15th, when news came out that Health Canada wanted to add nutrients to a wide variety of food, including junk food, such as chips and cookies (Health Canada weighs fortifying junk foods). Yesterday, a published news story elaborated on this a bit (Health C... Healthbolt blogs http://www.medworm.com/rss/comments.php?id=3115048 Wed, 23 Dec 2009 13:30:09 +0100 3115048 http://www.medworm.com/index.php?rid=2112467&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F8u5IIihKcbY%2F Ok - we’re back at the "XX is good for you, no it’s not" debate and, once again, it involves coffee. Let’s see what the experts are saying today: According to a study published in the journal American Journal of Epidemiology, people in the study who drank one or more cups of coffee per day cut their risk of developing oral cancers (mouth, pharynx esophagus) by half, compared with those who didn’t drink coffee regularly. Even more interesting is that this drop in risk also occurred in high-risk people whose smoking and alcohol consumption raised their risk of developing oral cancers. This wasn’t a small study either - almost 40,000 people took part and they were followed for 13 years. ~~~~ Image: MorgueFile.com Tags: cancer blog, oral cancer, coffee a... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=2112467 Sat, 17 Jan 2009 21:41:44 +0100 2112467 http://www.medworm.com/index.php?rid=1961312&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F-7O8F656kpU%2F A blog about cancer does, sadly, have to include some sad news from time to time - and this is one of those times. In December 2007, journalist, teacher, technical writer and website designer, Emru Townsend was diagnosed with a very aggressive form of leukemia. His only chance was getting bone marrow and the chance of finding a matching donor were very slim. Emru was of Caribbean descent and that ethnic group is sorely under-represented in the bone marrow registries of North America. Against all odds, a match was found and in early September 2008, Emru received a stem cell transplant and things looked up at first. Unfortunately, the leukemia was too strong and he lost his fight on November 11, at around 10 pm. Emru was a popular figure in the writing community. Many members of the Profes... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1961312 Fri, 14 Nov 2008 08:15:43 +0100 1961312 http://www.medworm.com/index.php?rid=1927924&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F6Ffctc86AcI%2F Patients with B-cell non-Hodgkin’s lymphoma (NHL) who have been treated with rituximab but whose lymphoma still progresses, may have hope with another treatment called Treanda (bendamustine hydrochloride). Indolent lymphoma, or lymphoma that resists treatment, is difficult to treat and is not currently curable. Treanda, while not a cure, may help slow down its progress. The United States FDA had already approved use of Treanda for the treatment of chronic lymphocytic leukemia (CLL). CLL is the most common form of leukemia in the United States. ~~~~ Tags: cancer blog, lymphoma, non hodgkin’s lymphoma, treanda, bendamustine Share This (Source: Cancer Commentary) Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1927924 Sun, 02 Nov 2008 21:58:23 +0100 1927924 http://www.medworm.com/index.php?rid=1769440&cid=t_143337_107_f&fid=36585&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FHighlightHEALTH%2F%7E3%2F383877706%2F Conclusion My thanks to everyone that contributed articles — it’s been great hosting the Cancer Research Blog Carnival for a second time this year. Be sure to take a moment and let your fellow bloggers know this issue is available so that everyone’s hard work can be appreciated and enjoyed by all. The Cancer Research Blog Carnival is looking for future hosts. You can find both the hosting schedule and past editions at the Cancer Research Blog Carnival website. For more information on the U.S. investment in cancer research, you can read the NCI’s plan and budget proposal for fiscal year 2009. References Niederhuber JE. A look inside the National Cancer Institute budget process: implications for 2007 and beyond. Cancer Res. 2007 Feb 1;67(3):856-62. View abstract The ... Highlight HEALTH blogs http://www.medworm.com/rss/comments.php?id=1769440 Fri, 05 Sep 2008 04:49:31 +0100 1769440 http://www.medworm.com/index.php?rid=1692422&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2FQDOpgT-ud-A%2F Scientists at the University of Florida College of Pharmacy found a marine compound that inhibits cancer cell growth in lab tests which they hope can lead to new anti-cancer drugs with fewer sides effects. The said UF-patented compound, called largazole was made from cyanobacteria that grow on coral reefs. Researchers, who described results from early studies today (Aug. 7) at an international natural products scientific meeting in Athens, Greece, say it is one of the most promising they’ve found since the college’s marine natural products laboratory was established three years ago. Largazole, discovered and named by Luesch for its Florida location and structural features, seeks out a family of enzymes called histone deacetylase, or HDAC. Overactivity of certain HDACs has been associat... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1692422 Sat, 09 Aug 2008 06:12:23 +0100 1692422 http://www.medworm.com/index.php?rid=1686600&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F6ZMvWe5fSAg%2F Tumor weight and growth rate has been reduced by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers with injections of high-dose Vitamin C (ascorbate or ascorbic acid). Such were the results reported by the NIH study at the Proceedings of the National Academy of Sciences (PNAS): The NIH researchers, however, tested the idea that ascorbate, when injected at high doses, may have prooxidant instead of antioxidant activity. Prooxidants would generate free radicals and the formation of hydrogen peroxide, which, the scientists hypothesized, might kill tumor cells. In their laboratory experiments on 43 cancer and 5 normal cell lines, the researchers discovered that high concentrations of ascorbate had anticancer effects in 75 percent of cancer cell lines tested, while spar... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1686600 Thu, 07 Aug 2008 03:43:45 +0100 1686600 http://www.medworm.com/index.php?rid=1683524&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2FPbkU2BRxEJg%2F A research team from Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have showed that combining a dietary agent with a gene-delivered cytokine effectively eliminates human pancreatic cancer cells in mice displaying sensitivity to these highly aggressive and lethal cancer cells. The cytokine used in this study was melanoma differentiation associated gene-7/interleukin-24, known as mda-7/IL-24. The dietary agent, perillyl alcohol (POH), was combined with mda-7/IL-24, which is already used in other cancer treatments. POH is found in a variety of plants, including citrus plants, and has been well-tolerated by patients who have received it in clinical studies. Published in the July issue of Molecular Cancer Therapeutics, their results indicated ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1683524 Tue, 05 Aug 2008 23:07:29 +0100 1683524 http://www.medworm.com/index.php?rid=1679664&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2FjoM0u6RljsM%2F Methadone - the agent used against opioid addiction - has been found by German researchers to have surprising killing powers against treatment-resistant forms of leukemia cells. Methadone, developed in Germany in the 1930s, is a low cost agent that acts on opioid receptors, and thus is used as an opioid substitute to treat addiction. Scientists have found that opioid receptors also exist on the surface of some cancer cells for reasons that are not understood. One research group tested the agent in human lung cancer cell lines and found that it can induce cell death. Thus suggesting that methadone has the potential as a new therapy for leukemia, more specifically in patients whose cancer no longer responds to chemotherapy and radiation. The said laboratory study finding was published in the... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1679664 Mon, 04 Aug 2008 21:59:29 +0100 1679664 http://www.medworm.com/index.php?rid=1668762&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F351321495%2F Amgen has recently been told by the FDA to reword the labeling of its flagship anemia drugs - Aranesp and Procrit - to further restrict their use in treating cancer patients. The move, which the F.D.A. announced on Wednesday, represents the first time the agency has invoked authority under a 2007 law that empowered it to order changes in a drug’s prescribing information. Previously, the F.D.A. could only negotiate with a drug’s manufacturer to change the label. Sales of the drugs, Aranesp and Procrit, have already plummeted in the last year because of studies suggesting that their use to treat the anemia caused by chemotherapy could actually make cancer worse or shorten lives. Procrit is manufactured by Amgen but sold under license by Johnson & Johnson. Read more from NY Times. Tag... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1668762 Thu, 31 Jul 2008 08:09:34 +0100 1668762 http://www.medworm.com/index.php?rid=1658234&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F348107526%2F I found a very nice read today, pointed out to me by Mike Street of Reader’s Digest Online: an article entitled 31 Simple Ways to Prevent Cancer. Some very practical tips presented in a sorta funny way but with a big ring of truth into it. Besides, before we all get rattled by the recent cancer scare on cellphone use and other stuff, really the prevention (or at least reducing our risk of developing any cancer later in life) all boils down to the dietary and lifetsyle changes each of us are willing to take, IMHO. Anyways, here goes in bullets only: Serve sauerkraut at your next picnic. Eat your fill of broccoli, but steam it rather than microwaving it. Toast some Brazil nuts and sprinkle over your salad. Pop a calcium supplement with vitamin D. Add garlic to everything you eat. Sau... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1658234 Mon, 28 Jul 2008 10:00:33 +0100 1658234 http://www.medworm.com/index.php?rid=1649361&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F344365061%2F This report has been causing a stir earlier this week. The good in the evil tobacco? So reports are saying. Okay before we all get too excited…the tobacco plants used are genetically engineered. To make the vaccine, researchers took a sample of a patient’s tumors, which in this trial were made up of B cells (white blood cells that help the body battle disease and infection). They then extracted the gene from the cells that coded for the antigen they needed (to help the immune system recognize the tumors as threats). The key, researchers say, was to make enough of the protein quickly to prompt an immune response. In this case, the scientists achieved this by inserting the gene into a plant microbe known a tobacco mosaic virus (TMV). Plants are infected with TMV simply by scratch... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1649361 Thu, 24 Jul 2008 08:00:06 +0100 1649361 http://www.medworm.com/index.php?rid=1637996&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F339122109%2F ImClone Systems, Inc.’s advanced colorectal cancer drug has now received regulatory approval in Japan. ERBITUX(R) (cetuximab) has received marketing authorization in Japan for use in treating patients with advanced or metastatic colorectal cancer (mCRC). Specifically, this approval allows for the use of ERBITUX to treat patients with epidermal growth factor receptor (EGFR)-positive, curatively unresectable (inoperable), advanced or recurrent CRC, and allows the use of ERBITUX plus irinotecan in second and further lines of mCRC. With this approval, ERBITUX is the first ever EGFR-targeted monoclonal antibody to be submitted for and receive marketing authorization in Japan. ERBITUX (cetuximab) is a monoclonal antibody (IgG1 Mab) designed to inhibit the function of a molecular structure ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1637996 Fri, 18 Jul 2008 16:00:28 +0100 1637996 http://www.medworm.com/index.php?rid=1631684&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F337199259%2F University of Texas M. D. Anderson Cancer Center researchers have identified tissue type transglutaminase (TG2) as potential therapeutic target in chemotherapy-resistant ovarian cancer. “….found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates. When researchers targeted and silenced TG2 in animal models, cancer progression was reversed, suggesting the protein may also provide a novel therapeutic approach for late-stage ovarian cancer.” Reported findings appear in the July 15th issue of Cancer Research. Read more from UT MD Anderson Cancer Center. Tags: chemotherapy-resistant ovarian cancer, late-stage advanced ovarian cancer, ovari... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1631684 Wed, 16 Jul 2008 16:00:22 +0100 1631684 http://www.medworm.com/index.php?rid=1603443&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F331357824%2F Some hormone-blocking drugs may not be beneficial to the elderly prostate cancer patients. Such were the findings of a new prostate cancer study. A prostate cancer study that could change how doctors treat some patients found that widely used hormone-blocking drugs did not improve survival chances for older men whose disease hadn’t spread. In fact, men given the drugs alone were slightly more likely to die of prostate cancer during the next six years than men who’d gotten medical monitoring but no or delayed treatment, another common treatment approach. The study involved nearly 20,000 Medicare patients with prostate cancer that hadn’t spread. A surprising 41 percent got only drug treatment, in shots or implants, showing that the therapy has become a popular alternative t... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1603443 Thu, 10 Jul 2008 03:18:23 +0100 1603443 http://www.medworm.com/index.php?rid=1596918&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F329575132%2F A molecule called STF-62247 has been discovered by Stanford University School of Medicine researchers to be toxic against kidney cancer cells but is generally harmless to most other cells in the human body. According to Amato Giaccia, PhD, professor and director of radiation oncology and radiation biology at the medical school: “You now have a potential means of going after a disease that’s been difficult to treat. There is no effective chemotherapy to treat renal cell carcinoma. Patients still succumb. Clinical trials could begin “in the next couple years”.” Above findings are published today in the journal Cancer Cell. Hopefully this discovery will in the future lessen the surgery option for kidney cancer treatment. Read more from Science Daily. Tags: anti-k... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1596918 Tue, 08 Jul 2008 07:05:09 +0100 1596918 http://www.medworm.com/index.php?rid=1535948&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F316685691%2F GlaxoSmithKline has won a contract with the UK’s NHS to supply its cervical cancer vaccine, Cervarix. The battle to supply a vaccine against cervical cancer for use across Britain has been won by GlaxoSmithKline (GSK). Cervarix, the GSK vaccine, will be given to girls aged between 12 and 13, starting in September this year, and should prevent about 70 per cent of cervical cancers — saving 400 lives a year when the effect is fully felt. Read more from The UK Times Online. Let’s wait and see what Merck (maker of the other cervical cancer vaccine Gardasil) has to say about this. Tags: CErvarix, cervical-cancer, cervical-cancer-vaccine, Gardasil, GlaxoSmithKline, Merck, UK NHSShare This (Source: Cancer Commentary) Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1535948 Sat, 21 Jun 2008 04:48:23 +0100 1535948 http://www.medworm.com/index.php?rid=1531832&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F315349454%2F Okay…here goes another news on flavonols from tea, onions, beans and apples. As suggested by findings of a new U.S. study, increased intake of such flavonols may reduce risk of colorectal cancer by as much as 76 percent. Findings were published in this month’s Cancer Epidemiology Biomarkers & Prevention: Analysis of data from a randomised dietary intervention trial showed that the overall class of flavonoid compounds was not associated with a risk reduction, but flavonols - a sub-group of flavonoids, did significantly reduce risk. The study adds to a growing body of science linking increased consumption of flavonol-rich foods, such as fruit and vegetables, to risk reductions for a range of cancers, including lung, pancreatic, and breast cancer. Flavonols, a sub-group of fla... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1531832 Thu, 19 Jun 2008 11:10:14 +0100 1531832 http://www.medworm.com/index.php?rid=1485038&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F302568867%2F Increased intake of certain flavonoids in smokers may protect them by as much as 50 percent against lung cancer risk. Such were the findings of a UCLA study: Increasing intakes of epicatechin, catechins, and quercetin, found in tea and vegetables were associated with significant risk reductions. According to lead researcher Zuo-Feng Zhang from UCLA’s Jonsson Cancer Center: “What we found was extremely interesting, that several types of flavonoids are associated with a reduced risk of lung cancer among smokers. The findings were especially interesting because tobacco smoking is the major risk factor for lung cancer.” But still, tobacco smoke must be skipped altogether, because smoking remains a major factor for lung cancer risk. It just so interesting how smokers were prot... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1485038 Sun, 01 Jun 2008 22:00:19 +0100 1485038 http://www.medworm.com/index.php?rid=1482545&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F301841391%2F ERBITUX® (Cetuximab) - product of Merck KGaA and ImClone Systems Inc. - has received EU backing as first-line treatment for colon cancer. According to the European Medicines Agency: Erbitux can be given as the first drug in colon-cancer treatment in patients who carry an unmutated kras gene, restricting its use to about 65 percent of patients. Erbitux is the first monoclonal antibody approved by the US FDA for the treatment of advanced colon cancer that has spread to the other parts of the body — either alone or in combination with other treatments. Read more about the EU backing on Erbitux from Bloomberg. Tags: colon-cancer, EMEA, ERBITUX® (Cetuximab), ImClone Systems Inc., MErck KGaAShare This (Source: Cancer Commentary) Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1482545 Sat, 31 May 2008 12:53:29 +0100 1482545 http://www.medworm.com/index.php?rid=1375200&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F271000486%2F Administration of the popular anti-inflammatory drug Celebrex (celecoxib, a nonsteroidal anti-inflammatory drug) in combination with Lipitor (atorvastatin, a cholesterol lowering drug or statin) halts the transition of early prostate cancer to its more aggressive and potentially deadly stage. “Anti-androgen therapy slows the prostate cancer but eventually the cancer becomes androgen-independent, the therapy becomes ineffective and the cancer cells become more aggressive,” said Xi Zheng, assistant research professor at Rutgers, The State University of New Jersey, who conducted the study. “Treatments available for the later stage cancers are not very good,” said Allan Conney, director of Rutgers’ Susan Lehman Cullman Laboratory for Cancer Research, another resea... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1375200 Tue, 15 Apr 2008 22:02:12 +0100 1375200 http://www.medworm.com/index.php?rid=1368007&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F268693433%2F In a mice study, the green tea compound EGCG has been found to significantly inhibit breast cancer growth. EGCG (epigallocatechin-3- gallate) is a known antioxidant — helps prevent the body’s cells from becoming damaged and prematurely aged. Studies have suggested that the combination of green tea and EGCG may also be beneficial by providing protection against certain types of cancers, including breast cancer. A new study conducted by researchers at the University of Mississippi researchers now finds that consuming EGCG significantly inhibits breast tumor growth in female mice. These results bring us one step closer to better understanding the disease and potentially new and naturally occurring therapies. Hmmm…green tea! Don’t you just love it? ;-) Find more details fro... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1368007 Sat, 12 Apr 2008 00:37:09 +0100 1368007 http://www.medworm.com/index.php?rid=1344650&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F262710483%2F I got this from the Belfast Telegraph: Thousands of people in Northern Ireland are increasing their long-term risk of cancer and obesity by skipping breakfast and turning to sugary and fatty snacks instead. Ugh. Isn’t that exactly the case, practically anywhere?! Point in case: the western world, the modern world, in Asia! Anywhere, right? Unhealthy eating habits, diets will lead to obesity, cardiovascular diseases and of course…Cancer! A new survey commissioned by the leading charity found that 25% of people in Northern Ireland miss breakfast at least twice a week. It found that nearly half of respondents (48%) admitted to snacking on fatty and sugary foods such as crisps, biscuits, cakes and sweets to keep morning hunger at bay. Experts estimate that about a quarter of all c... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1344650 Wed, 02 Apr 2008 14:52:16 +0100 1344650 http://www.medworm.com/index.php?rid=1332793&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F259586803%2F Antioxidants in grape skins and red wine can kill pancreatic cancer cells by getting into the center of the cell’s energy - the mitochondria- thereby disabling its function. Such were the findings of a team from University of Rochester Medical Center. The new study also showed that when the pancreatic cancer cells were doubly assaulted — pre-treated with the antioxidant, resveratrol, and irradiated — the combination induced a type of cell death called apoptosis, an important goal of cancer therapy. Although red wine consumption during chemotherapy or radiation treatment has not been well studied, it is not “contraindicated,” Okunieff said. In other words, if a patient already drinks red wine moderately, most physicians would not tell the patient to give it up ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1332793 Fri, 28 Mar 2008 11:32:47 +0100 1332793 http://www.medworm.com/index.php?rid=1303512&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F251286999%2F March is National Nutrition Month. Here at Cancer Commentary, we are crazy about food too, especially those that have anti-cancer properties! To support the National Nutrition Month, here inside the b5media Science and Health Channel, we pay tribute to nutrition and how it relates to respective blogs in the channel. Check out the theme day post, written by Ruth Schaffer of Eating Fabulous. Holy cow! It’s already Friday…enjoy your weekend guys!! ;-) Tags: B5media, diet, Eating Fabulous, food, National Nutrition Month, Science-and-Health-Channel, Theme DayShare This (Source: Cancer Commentary) Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1303512 Fri, 14 Mar 2008 09:30:32 +0100 1303512 http://www.medworm.com/index.php?rid=1301914&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F251076162%2F An allergic reaction to the cancer drug cetuximab has been found. Sometimes the reaction includes anaphylaxis, a life-threatening condition characterized by a drop in blood pressure, fainting, difficulty breathing, and wheezing. Now researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have discovered that specific pre-existing antibodies cause the severe reaction to the drug. Cetuximab is an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer, marketed as the popular brand Erbitux — a product of ImClone Systems Inc. and Bristol-Myers Squibb Company. Find more details from NIAD/NIH. Tags: allergic reaction, cancer-drug, cetuximab, colorectal-cancer, Erbit... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1301914 Fri, 14 Mar 2008 00:19:39 +0100 1301914 http://www.medworm.com/index.php?rid=1297988&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F250183262%2F It has all been said so many times already that one’s diet plays a big role in cancer and cancer prevention. Although that is true, we cannot just decide one day to pick up a healthier diet (like increasing the intake of fruits and veggies!!) and be assured we won’t increase or risk of developing any cancer type. One cannot just erase one’s history of unhealthy eating and lifestyle, right? How can one erase something like not giving fruits, veggies and fish a second look during the first 30 years of your life?! Ever heard of the words: from cradle to grave? That’s also the period of time we all should be living healthy, not only against cancer but also against any other serious medical condition. As of late, here are the most recent reports that involves nutrition ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1297988 Wed, 12 Mar 2008 15:22:42 +0100 1297988 http://www.medworm.com/index.php?rid=1281071&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F246202699%2F According to a study of more than 77,000 vitamin users , intake of some vitamin supplements do not protect against lung cancer, especially in smokers. Said the study’s author, Christopher G. Slatore, M.D., of the University of Washington, in Seattle: “Our study of supplemental multivitamins, vitamin C, vitamin E and folate did not show any evidence for a decreased risk of lung cancer. Indeed, increasing intake of supplemental vitamin E was associated with a slightly increased risk of lung cancer.” Such were the findings of Dr. Slatore and colleagues from selected prospective cohort of 77,126 men and women between 50 and 76 years of age in the Washington state VITAL (VITamins And Lifestyle) study. From the said population, the team determined their rate of developing lung ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1281071 Wed, 05 Mar 2008 16:14:12 +0100 1281071 http://www.medworm.com/index.php?rid=1268660&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F243261697%2F Vitamin D has the potential to become the “new aspirin“, the little inexpensive pill that may be able to block the development of some cancers, strengthen bones, prevent multiple sclerosis and alleviate winter depression. Such were the findings of a new Canadian study: But it’s not science fiction. The “new aspirin” could be Vitamin D. Just as we discovered that aspirin can guard against heart disease, Vitamin D could become a useful weapon in the fight against MS, osteoporosis, mild depression and one of the most devastating diseases of our time – cancer. “As time has gone by, Vitamin D has raised its head as a sort of ambrosia for cancers,” says Dr. Louise Parker, an epidemiologist and a world expert in the environmental exposures that can lead to cancer. Or, in t... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1268660 Fri, 29 Feb 2008 11:17:14 +0100 1268660 http://www.medworm.com/index.php?rid=1218317&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F231509690%2F That may not be unheard of according to a clinical study of a team headed by the international Ludwig Institute for Cancer Research (LICR): What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years? …has shown that a vaccine against a protein found in cancer cells produces an immune response that can be boosted and strengthened with additional vaccine shots. Patients with resected non-small cell lung cancer (NSCLC) were treated with this investigational agent, also known as an Antigen-Specific Cancer Immunotherapeutic (ASCI), in another clinical study conducted by GlaxoSmithKline. The results showed a reduction in risk of cancer recurrence in these patients, a finding that prompted GlaxoSmithKline to initiate the larges... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1218317 Fri, 08 Feb 2008 10:08:26 +0100 1218317 http://www.medworm.com/index.php?rid=1212340&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F230245772%2F Uganda is one among a few developing countries lined up to benefit from the first cervical cancer vaccine trial project to be implemented by the Programme for Appropriate Technology in Health (PATH). PATH is a non governmental organisation hoping to come up with a cervical cancer vaccine by year 2010. Young women in India, Peru, Uganda, and Vietnam will become the first in the developing world to live without fear of cervical cancer-as PATH and our partners begin pilot introduction of new vaccines for the disease,” reads a statement on the organisation’s website. In 2005, cancer killed approximately 14,000 people in Uganda. 8,000 of those were under the age of 70. Of the various cancers, cervical cancer remains the most common cancer killing women in Uganda according to the Wor... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1212340 Wed, 06 Feb 2008 11:50:18 +0100 1212340 http://www.medworm.com/index.php?rid=1187255&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F225558102%2F Before it was an aspirin a day keeps the heart doctor away. Now, according to a study published in Gastroenterology (the official journal of the American Gastroenterological Association (AGA) Institute), the use of regular, long-term aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) reduces the risk associated with colorectal cancer. According to Andrew T. Chan, MD, MPH, Massachusetts General Hospital and lead author of the study: “While the results of our study show that aspirin should not currently be recommended for the chemoprevention of colorectal cancer in a healthy population, there is a need for further studies to help identify for which patients the potential benefits outweigh the risks. We also need to improve our understanding of how aspirin works to prevent and i... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1187255 Wed, 30 Jan 2008 00:00:10 +0100 1187255 http://www.medworm.com/index.php?rid=1184760&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F224881823%2F Last week, came out interesting new findings on ovarian cancer. New developments revealed that cigarette smoking and alcohol consumption do not have an effect on ovarian cancer risk. However, caffeine intake may lower the risk of developing ovarian cancer, particularly in women not using hormones. Such were the findings published in the March 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society. There was no association between current or past smoking and ovarian cancer risk, however smoking status, duration, and pack-years were significantly associated with risk of mucinous tumors, a rare form of ovarian cancer. The authors also found no association between alcohol consumption and ovarian cancer risk. However they observed an inverse trend of risk with total caf... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1184760 Tue, 29 Jan 2008 00:00:56 +0100 1184760 http://www.medworm.com/index.php?rid=1176219&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F222582280%2F According to a study that appeared online in the January 22 issue of Lancet Oncology, patients taking Nexavar® (sorafenib) need to be carefully monitored and treated. In clinical testing, Nexavar improved overall survival by 44 percent among people with HCC. Median overall survival was 10.7 months among those treated with the drug, versus 7.9 months among those who took a placebo. This was considered a major inroad against one of the most voracious cancers. Nexavar is also being assessed to treat small-cell lung cancer, prostate cancer and melanoma.Earlier trials, however, had shown a 16 percent to 42.6 percent incidence of hypertension in patients taking the drug. If not properly controlled, hypertension can lead to strokes and heart attacks, as well as kidney failure. For this paper, re... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1176219 Fri, 25 Jan 2008 00:00:41 +0100 1176219 http://www.medworm.com/index.php?rid=1142789&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F214472762%2F According to Wildon Farwell, M.D., of the Veterans Affairs Boston Healthcare System and colleagues, patients that are on cholesterol-lowering drugs – statins – may be at a lower risk for developing cancer — especially lung and colorectal cancers. Statin users had a reduced risk of all cancer types compared with non-statin users. The incidence of cancer was 9.4 percent among statin users and 13.2 percent among non-statin users. “Our findings support the hypothesis that statins may reduce the risk of cancer, in particular lung and colorectal cancers. This relationship may be affected by the [statin dose],” the authors write. While it is not known if statins can directly prevent cancer, they may inhibit growth of cancer cells – at least according to lab studies. Find m... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1142789 Thu, 10 Jan 2008 16:01:08 +0100 1142789 http://www.medworm.com/index.php?rid=1141024&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F214242047%2F The Moffitt Cancer Center in Tampa, Florida is seeking patients who have primary liver cancer (hepatocellular carcinoma) that has spread to other organs or is too advanced to be treated by surgery and must have had prior chemotherapy treatments. The said patients are being recruited by Moffitt for the phase II study of the oral medication AZD6244 — an experimental anti-cancer drug that may stop the growth of cancer cells and is designed to block the pathway of a protein called MEK (important for cell survival). According to Dr. Chris R. Garrett, principal investigator with Moffitt’s Gastrointestinal Oncology program: “There’s no cure for advanced liver cancer that’s not amenable to surgery. We’re looking for a novel therapy to improve the outcome for patients with the disea... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1141024 Thu, 10 Jan 2008 07:14:45 +0100 1141024 http://www.medworm.com/index.php?rid=1129518&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F210922900%2F This study demonstrates that the benefits of short-term hormonal therapy for men receiving radiation therapy for prostate cancer far outweigh the risks. While four months of hormonal therapy isn’t enough to cause significant side effects, we found that it can delay the development of bone metastasis by as many as eight years, which is very significant. So by taking a little bit of hormonal therapy early, patients may avoid having to take a lot of it later.” The study is published online January 2 in the Journal of Clinical Oncology. Find more details from American Society of Clinical Oncology. Share This (Source: Cancer Commentary) Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1129518 Fri, 04 Jan 2008 05:06:23 +0100 1129518 http://www.medworm.com/index.php?rid=1118271&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F206902926%2F A new experimental drug has been found by Oregon Health & Science University (OHSU) Cancer Institute researchers to be effective against a highly resistant mutation in chronic myeloid leukemia (CML). The said new drug candidate - SGX393 - has been found to inhibit most resistant mutations — including T315I — both in mouse models and in patient cells in laboratory studies. This drug candidate could build on the legacy of Gleevec, which has been the gold standard for treating this leukemia and was developed by Brian Druker, M.D., director of the OHSU Cancer Institute. Despite Gleevec’s success, some CML patients develop resistance to Gleevec, often due to mutations that interfere with drug binding. The second-generation drugs Sprycel and Tasigna have been developed as large... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1118271 Thu, 27 Dec 2007 07:50:46 +0100 1118271 http://www.medworm.com/index.php?rid=1098926&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F201532562%2F In this study, 14 extracts were found to be active in inhibiting prostate cancer cells. The findings - active extracts from Ganoderma lucidum were found to be the most effective in inhibiting the function of the androgen receptor and controlling vital development of cancerous cells – is a new, interesting and very promising development in the fight against cancer. Find more details from the University of Haifa. Share This (Source: Cancer Commentary) Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1098926 Mon, 17 Dec 2007 08:23:28 +0100 1098926 http://www.medworm.com/index.php?rid=1097503&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F201130924%2F Speaking of breast cancer… Previously popular treatments – i.e. big-dose chemotherapy – apparently are of no help against breast cancer. Such were the findings recently reported by a group of Houston researchers. A grueling and controversial breast cancer treatment that was popular in the late 1980s and the 1990s does not extend the lives of patients in advanced stages of the disease In releasing their report on a review of existing studies, the researchers said women who received high-dose chemotherapy, followed by transplants from their own bone marrow, fared no better than patients on other therapies. Donald Berry, head of quantitative studies at the University of Texas M.D. Anderson Cancer Center and the review’s lead investigator, said: “This shows more is not ne... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1097503 Sun, 16 Dec 2007 11:00:46 +0100 1097503 http://www.medworm.com/index.php?rid=1088870&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F199095375%2F The targeted cancer pill – Gleevec - has been approved for the treatment of gastrointestinal stromal tumors, pediatric CML, as well as five additional rare cancers. While it has been reported to have saved more than 100,000 lives, Gleevec is now saving more children with a dire leukemia (Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) ), as well as preventing disease progression with long term use in adults with chronic myeloid leukemia (CML). Such were the data reported by Oregon Health & Science University (OSHU) at the recent annual meeting of the American Society of Hematology: “Data at this weekend’s meeting continues to show how much Gleevec has completely changed the outlook for so many, many patients facing cancer. Researchers delivered news that G... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1088870 Wed, 12 Dec 2007 09:31:10 +0100 1088870 http://www.medworm.com/index.php?rid=1083002&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F197918484%2F We already know that smokers have a higher risk of developing lung cancer. However, smokers and non-smokers alike may be able to substantially reduce the risk of developing lung cancer by simply eating four or more servings of green salad a week and working in the garden once or twice a week. Such were the findings of researchers at The University of Texas M. D. Anderson Cancer Center. According to Michele R. Forman, Ph.D., lead author of the study and a professor in M. D. Anderson’s Department of Epidemiology: “This is the first risk prediction model to examine the effects of diet and physical activity on the possibility of developing lung cancer. The data are from an ongoing M. D. Anderson case-control lung cancer study involving more than 3,800 participants. Separate epidemi... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1083002 Mon, 10 Dec 2007 07:38:15 +0100 1083002 http://www.medworm.com/index.php?rid=1081640&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F197165130%2F I’ve blogged on and on above the beneficial effects of a fruits-and-vegetable-rich diet against cancer. Though the effects are not immediate, in the long run, such diet has a role on cancer prevention. Now, there is new evidence for the protective effects of fruits and vegetables. Researchers presented at the American Association for Cancer Research’s Sixth Annual International Conference on Frontiers in Cancer Prevention, new data that demonstrate how diets full of raw vegetables –particularly broccoli sprouts — and black raspberries could prevent or slow the growth of some common forms of cancer. You will have to read the full article from Science Daily, but the highlights are the following: Black raspberries modulate markers of oxidative stress in patients with Barr... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1081640 Sat, 08 Dec 2007 14:49:46 +0100 1081640 http://www.medworm.com/index.php?rid=1072508&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F195558509%2F The powerful anti-cancer drug imatinib (Gleevec™) has been re-engineered by researchers at Rice University and the University of Texas M. D. Anderson Cancer Center. Developed by Novartis Pharmaceuticals, Gleevec is approved by the U.S. Food and Drug Administration for the treatment of chronic myeloid leukemia (CML), Philadelphia-chromosome positive acute lymphoblastic leukemia and GIST. The drug targets two proteins that have been linked with cancer. One of its targets is the C-Kit kinase, a protein that has been tied to gastrointestinal cancer, and another is Bcr-Abl kinase, a key protein controlling CML. Not just for kicks, mind you, but to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect. In a new study, it has been ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1072508 Wed, 05 Dec 2007 15:13:58 +0100 1072508 http://www.medworm.com/index.php?rid=1058460&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F192312880%2F We know how green tea has become popular for its anti-cancer ingredients. Now, Moffitt Cancer Center is looking for volunteers/participants in a green tea study: Moffitt Cancer Center is looking to recruit and treat 240 men and evaluate safety and effectiveness of Polyphenon E, a drug developed from green tea, in preventing the progression of early signs of prostate cancer. The goal is to also assess if Polyphenon E reduces urinary tract symptoms that men experience with this condition. The following male participants are needed: between the ages of 30 and 80 have had a biopsy-proven high-grade prostatic intraepithelial neoplasia (HGPIN) have no prior history of other cancers (other than nonmelanoma skin cancer) have no history of liver disease have the ability to take the study drug and ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1058460 Thu, 29 Nov 2007 10:21:05 +0100 1058460 http://www.medworm.com/index.php?rid=1049094&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F190478238%2F CBD, a compound found in Cannabis Sativa (or marijuana) may prove to be effective in helping stop the spread of breast cancer cells throughout the body. Such were the findings by scientists at the California Pacific Medical Center Research Institute. CBD could be the first non-toxic agent to show promise in treating metastatic forms of breast cancer. According to Sean D. McAllister, Ph.D., a cancer researcher at CPMCRI and the lead author of the study: “Right now we have a limited range of options in treating aggressive forms of cancer. Those treatments, such as chemotherapy, can be effective but they can also be extremely toxic and difficult for patients. This compound offers the hope of a non-toxic therapy that could achieve the same results without any of the painful side effects.” ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1049094 Mon, 26 Nov 2007 02:03:48 +0100 1049094 http://www.medworm.com/index.php?rid=1048755&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F190060954%2F According to a new study in mice (led by Zhenhua Liu from Tufts University), moderate deficiency of folate, riboflavin, and vitamins B6 and B12 together may promote the risk of DNA damage and increase the risk of colorectal cancers. The researchers, led by Zhenhua Liu from Tufts University, studied the Wnt pathway - a cellular signalling pathway linked to more than 85 per cent of colon cancers - and found that mild depletion of all four B vitamins was needed to promote the risk of tumour formation. Previously, studies have suggested that folate deficiency alone may promote the risk of colorectal cancer. The new research suggests a more complex interaction. However, the subject of folate and colorectal cancer is controversial, however, with some studies reporting that the B-vitamin may in f... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1048755 Sun, 25 Nov 2007 02:41:15 +0100 1048755 http://www.medworm.com/index.php?rid=1046824&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F189247175%2F This study shows that this new class of drugs is a critical advance toward meeting that need. The last five to ten years have been the most wonderful time to be a physician treating multiple myeloma, thanks to advances like lenalidomide. Twenty, thirty years ago, there wasn’t much we could do for these patients. We couldn’t really treat the disease effectively so we tried to treat the symptoms with only two or three types of chemotherapy and radiation, which of course have their own negative side-effects. Now, we have this new, highly effective class of drugs with very low side effects. Before, we hoped for a positive response in patients. Now, we expect one. Thanks to new agents like lenalidomide, we’ve been able to convert this disease from a killer to more of a chronic... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1046824 Fri, 23 Nov 2007 09:48:39 +0100 1046824 http://www.medworm.com/index.php?rid=1041950&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F188086980%2F Frequent consumption of foods containing the flavonoid kaempferol, including nonherbal tea and broccoli and consumption of large amounts of the flavonoid luteolin, which is found in foods such as carrots, peppers, and cabbage – have been found associated with a reduced risk of ovarian cancer. Such were the findings of a new research from the Channing Laboratory at Brigham and Women’s Hospital (BWH). According to first author Margaret Gates, a research fellow at BWH and at the Harvard School of Public Health: “This is good news because there are few lifestyle factors known to reduce a woman’s risk of ovarian cancer. Although additional research is needed, these findings suggest that consuming a diet rich in flavonoids may be protective. In this population of women, consumption of no... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1041950 Wed, 21 Nov 2007 04:27:43 +0100 1041950 http://www.medworm.com/index.php?rid=1037901&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F187705314%2F According to University of California - Irvine cancer researchers, low doses of freeze-dried grape powder inhibit genes linked to the development of sporadic colorectal cancer. Thereby suggesting that a grape-rich diet may help prevent the third most common form of cancer, one that kills more than a half a million people worldwide each year – colorectal cancer. Led by Dr. Randall Holcombe, director of clinical research at the Chao Family Comprehensive Cancer Center at UC Irvine, the study followed up on previous in vitro studies showing that resveratrol, a nutritional supplement derived from grape extract, blocks a cellular signaling pathway known as the Wnt pathway. The Wnt pathway has been linked to more than 85 percent of sporadic colon cancers, which is the most common form of colon ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1037901 Tue, 20 Nov 2007 13:14:52 +0100 1037901 http://www.medworm.com/index.php?rid=1030295&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F185417876%2F We already know that antioxidants have anti-canter powers. Among those with antioxidants, green tea is my favourite. Not only because it has been mentioned numerous times in this blog against various cancers, but because I love drinking green tea too. I know that liking green tea is an acquired taste. Not everybody likes it immediately. Bu because I had colleagues who visits Japan regularly for research work, they always brought me packs of green tea when they get home. So I guess the taste of green tea grew on me. Now, according to a Purdue University research, adding citrus juice to your cup of green tea increases the power of green tea. To get more out of your next cup of tea, just add juice. A study found that citrus juices enable more of green tea’s unique antioxidants to rem... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1030295 Thu, 15 Nov 2007 21:01:02 +0100 1030295 http://www.medworm.com/index.php?rid=1025529&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F184509342%2F According to a new study, brachytherapy (radiation seed implants) are just as effective at curing prostate cancer in younger men (aged 60 and younger) as they are in older men. Brachytherapy is a minimally invasive procedure where a radiation oncologist places small radioactive seeds into the prostate in order to kill the cancer cells. It is an attractive treatment option for patients with prostate cancer because it has a much shorter recovery time than surgery and studies have shown brachytherapy to be just as effective as surgery. Normal practice of surgeons have always been to advice younger men to undergo surgery to remove all or part of the prostate (prostatectomy) over other treatments like seed implants because they believed younger men could physically tolerate surgery, plus they b... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1025529 Wed, 14 Nov 2007 06:26:20 +0100 1025529 http://www.medworm.com/index.php?rid=1020091&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F183396354%2F According to a new study from St. Jude Children’s Research Hospital, the anti-leukemia drug dexamethasone contributes to a relentless fatigue and poor quality of sleep in children undergoing treatment for acute lymphoblastic leukemia (ALL) – thereby suggesting that clinicians could improve the quality of life for these children by developing new methods of drug administration that reduce or eliminate these side effects. Although effective in the treatment of ALL, dexamethasone could also cause a variety of side effects in children, including fatigue. The St. Jude team showed that dexamethasone significantly increased patients?fatigue, length of daytime naps, frequency of awakening at night and the amount of restlessness during sleep. The findings also suggest that before initia... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1020091 Mon, 12 Nov 2007 04:59:47 +0100 1020091 http://www.medworm.com/index.php?rid=1010678&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F180972938%2F Curcumin has long been known for its anti-cancer properties. Curcumin is the yellowish component of turmeric that gives curry its flavor. I am not a fan of dishes that use curry. However, if cooked just right I may actually like it. My mother’s version of chicken curry (not too pungent but not bland either) is one of my favorites. Now, Japanese researchers reported that two molecular analogues of curcumin demonstrate even greater tumor suppressive properties. The team presented their findings from the first test of these molecules in a mouse model of colorectal cancer November 5 at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine. According to Tohoku University researcher Hiroyuki Shibata, M.D., curcumin is one of the most widely studie... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1010678 Wed, 07 Nov 2007 08:04:36 +0100 1010678 http://www.medworm.com/index.php?rid=1003724&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F179836555%2F Bevacizumab is a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels. Now, a new study found that bevacizumab may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer. Ovarian cancer or cancer of the ovary is the fifth most common cancer in women and I reckon one of the deadliest. Almost 70% of ovarian cancer patients fail to win against the disease despite chemotherapy. According to Dr. Bram Goldstein, co-author of the study, whose findings are published in Vol. 17 Issue 4 of International Journal of Gynecological Cancer: “The results from our research suggest that the combination of Bevacizumab and standard therapy for the treatment of ovarian cancer may be promising, particularly with... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1003724 Mon, 05 Nov 2007 02:47:01 +0100 1003724 http://www.medworm.com/index.php?rid=989974&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F177011659%2F Thallion Pharmaceuticals’ novel anti-cancer drug which offers two modes of action – ECO-4601 – showed positive results from its Phase I/II clinical trial. According to Pierre Falardeau, Ph.D., chief operating officer at Thallion Pharmaceuticals in Montreal, Canada: ”In 26 patients with advanced solid tumors, treatment with ECO-4601 is safe and well tolerated, including at doses yielding plasma concentrations above the expected therapeutic threshold. ECO-4601 has a unique mechanism of action comprising two distinct activities. It inhibits the RAS/MAPK intracellular signaling pathway, which is mutated in many cancer types, and which is the target of several approved cancer drugs such as Erbitux, Avastin, Tarceva, Nexavar, and Sutent. However, unlike these drugs, our preclinical exper... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=989974 Tue, 30 Oct 2007 04:30:03 +0100 989974 http://www.medworm.com/index.php?rid=974757&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F174175005%2F I am literally under a very bad weather. Meanwhile, I hope your enjoy and find informative, the following cancer links: Heparanase Inhibitor, Potential Anti-Cancer Drug Candidate Cancer Prevention, Diet and Functional Foods Women Opting for Double Mastectomies Breast Cancer Victims Subject to Hurtful Reactions Share This (Source: Cancer Commentary) Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=974757 Wed, 24 Oct 2007 06:21:10 +0100 974757 http://www.medworm.com/index.php?rid=971536&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F173709006%2F Cancer is said to be metastatic once cancer in one body spreads to other body parts. In lay man’s term, the spreading of cancer to other locations. When cancer becomes metastatic, it becomes an advanced stage cancer that is most often difficult to treat because the cancer becomes unresponsive to typical treatment. Like metastatic breast cancer that becomes unresponsive to two chemotherapy treatments that include an anthracycline (such as doxorubicin or epirubicin) and a taxane (such as paclitaxel or docetaxel). This is where new anti-cancer treatment Ixempra comes in that is recently approved by the FDA. The approval of Ixempra includes the following: for use in combination with another cancer drug (capecitabine) in patients who no longer benefit from two other chemotherapy treatmen... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=971536 Tue, 23 Oct 2007 08:34:36 +0100 971536 http://www.medworm.com/index.php?rid=959881&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F171582588%2F Rain clouds seem to have made my part of the world its indefinite home. The skies over us haven’t been clear for a week now and looks like will stay that way for several more days that hopefully won’t make it to Christmas-time like it did last year. The words low pressure area, monsoon rains sound like the new mantra of the daily weather bulletin. For someone like me relying on wireless internet and satellite TV, non-stop heavy rains are not good, hugely affecting all the signal that I need. And then the electricity went out for a whole eight hours today. Not good. Not good at all. Maybe unimaginable in the western world, but here in the east, stuff like these really do happen. It sucks. Big time. But that’s life our life. So we accept it. And we move on. Meanwhile, under... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=959881 Thu, 18 Oct 2007 12:44:05 +0100 959881 http://www.medworm.com/index.php?rid=954478&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F170523556%2F We could go on and on about anti-cancer ingredients found in plants, vegetables and fruits but we all know that most anti-cancer ingredients found in plant extracts won’t have the beneficial effects unless we eat a daily truck-load of such plant of fruit. It is in this situation that such ingredients needed to be extracted from it source and made into a stable form in a capsule or juice drink for example that we can easily take orally. But what if only small amounts can be extracted even from loads amount of the said plant source? If the said anti-cancer compounds cannot be synthesized in the lab, that will be the dead-end of the said anti-cancer compound even if how potent it is in fighting or killing cancer. That is exactly the case of two potent, but rare naturally occurring molec... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=954478 Tue, 16 Oct 2007 08:03:37 +0100 954478 http://www.medworm.com/index.php?rid=950986&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F169931375%2F According to a new study from Japan’s National Cancer Center, drinking five cups of green tea a day may reduce the risk of prostate cancer by 48%. The Japan Public Health Center-based Prospective Study (JPHC Study) studied 49,920 Japanese men aged from 40 to 69. The participants completed a questionnaires at the start of the study to identify dietary intakes, including their habitual green tea consumption. The study, initially established in 1990, followed the men through until 2004, and 404 cases of prostate cancer were diagnosed in this time. Of these cases, 114 were advanced cases, 271 were localized, and 19 were undeterminable. The researchers admitted that they do not know exactly which one of the components of the beverage may be responsible for the benefits, and whether such e... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=950986 Mon, 15 Oct 2007 01:52:54 +0100 950986 http://www.medworm.com/index.php?rid=934136&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F166739483%2F The drug imatinib has been found to drive cancer into remission in people with chronic myeloid leukemia (CML). But CML often returns when treatment is stopped. Now, according to a new research by a team from UC-Irvine, imatinib could cure CML under certain circumstances if it is taken over a long enough period of time. According to mathematician Natalia Komarova and biologist Dominik Wodarz (respectively): “There is evidence that a complete cure is possible. Several patients have been reported to have no symptoms after two months without therapy, which is thought to suggest a complete cure. This evidence supports our theory. Basically, one has to be on therapy long enough for all of the stem cells to wake up and be killed by the drug. The model requires the number of cancer cells tha... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=934136 Mon, 08 Oct 2007 01:45:14 +0100 934136 http://www.medworm.com/index.php?rid=926372&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F165084028%2F It may not be the best of combination, but a diet rich in onions, apples and berries may reduce the risk of prostate cancer by about 25%. The flavonols found in foods such as onions, apples and berries is the one responsible for the said association. Such were the findings of a multi-ethnic study conducted by a team from German Institute of Human Nutrition Potsdam-Rehbruecke. The researchers also stated that theirs is the first study to examine prospectively specific classes of flavonols (quercetin, found in onions and apples; kaempferol, found in spinach and some cabbages; and myricetin, found mostly in red onions and berries) and pancreatic cancer risk. Of the three individual flavonols, they report that kaempferol was associated with the largest risk reduction (22 per cent) across all ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=926372 Thu, 04 Oct 2007 07:35:13 +0100 926372 http://www.medworm.com/index.php?rid=901030&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F161036890%2F Speaking of cervical cancer vaccines, there are two notables: Gardasil by Merck which was approved by the FDA earlier this year and Cervarix by GlaxoSmithKline which is expected to be approved by the FDA later this year (but already approved in Australia). Regarding these HPV vaccines that will protect women against cervical cancer, the CDC recommends that the vaccine should be routinely given to girls at 11-12 years of age – the stage before young girls are more likely to become sexually active. Now there is a new project that will evaluate and monitor the effectiveness of these vaccines. The said project -funded by the national Centers for Disease Control and Prevention (CDC) - will be jointly conducted by the University of Rochester Medical Center (URMC) and the New York State Depart... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=901030 Tue, 25 Sep 2007 11:58:23 +0100 901030 http://www.medworm.com/index.php?rid=886467&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F158926169%2F Vitamin C is an antioxidant (it captures volatile oxygen free radicals) — is the prevailing theory why Vitamin C is an anti-cancer agent. A new theory has come up: Vitamin C may block growth of tumors by destabilizing their ability to grow under oxygen-starved conditions – according to a new study from a team from The Johns Hopkins University. The team was alerted to a new possible mechanism of antioxidant functioning when it examined cancer cells from those cancer-implanted mice that were not fed antioxidants. There was an absence of any significant DNA damage in these mice. This led the authors to suspect some other mechanism was involved, such as a protein known to be dependent on free radicals called HIF-1 (hypoxia-induced factor). This new finding – published and reported th... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=886467 Thu, 20 Sep 2007 08:56:37 +0100 886467 http://www.medworm.com/index.php?rid=876217&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F157511226%2F The generic drug finasteride not only can shrink an enlarged prostate and reduce the risk of getting prostate cancer by 25 percent – the drug can also raise the chances that doctors can detect prostate cancer early. It has already been said so many times (in any cancer type) that earliest detection of the cancer is always good because that’s when the cancer is most easily treatable and thus the higher chance of survival in patients. Such were the findings of the Southwest Oncology Group (SWOG) –headquartered at the University of Michigan. According to Ian M. Thompson, M.D., the study’s senior author and a urologist at the University of Texas Health Science Center in San Antonio: “It appears that a man concerned about prostate-cancer risk, who is having a PSA test ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=876217 Mon, 17 Sep 2007 09:03:10 +0100 876217 http://www.medworm.com/index.php?rid=853256&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F154080254%2F Lung cancer is most often difficult to treat. Not only because it cannot be detected early enough but also because most lung cancer tumors aren’t that responsive to treatment. Therefore scientists are always looking for the good if not the best treatment combination for lung cancer. One example is the new mice study from UT Southwestern Medical Center: Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone. The said drug is bavituximab – a drug which Peregrine Pharmaceuticals Inc. has exclusively licensed from UT Southwestern. Said Dr. Philip Thorpe, professor of pharmacology at UT Southwestern: “This tells us that there is an ... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=853256 Sun, 09 Sep 2007 04:49:34 +0100 853256 http://www.medworm.com/index.php?rid=839150&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F151910480%2F The experimental compound cyclopamine was previously known to shut down a critical cell-signaling pathway (Hedgehog) in the most common and aggressive type of adult brain cancer: glioblastoma multiforme. Now, according to Johns Hopkins scientists, cyclopamine have been able to successfully kill cancer stem cells thought to fuel tumor growth and help cancers evade drug and radiation therapy. According to Charles G. Eberhart, M.D., Ph.D., associate professor of pathology, ophthalmology and oncology, who led the work: “Our study lends evidence to the idea that the lack of effective therapies for glioblastoma may be due to the survival of a rare population of cancer stem cells that appear immune to conventional radiation and chemotherapy. Hedgehog inhibition kills these cancer stem cells... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=839150 Tue, 04 Sep 2007 05:46:43 +0100 839150 http://www.medworm.com/index.php?rid=833389&cid=t_143337_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F08%2F31%2Fthought-for-the-day-sit-down-and-eat-a-family-meal-of-fruit%2F Filed under: Thought for the DayI'm a huge believer in the power of foods to battle the ravages of cancer among other things. In a household I know of that contains a cancer survivor, the family gets together one time a week to have dinner around the dinner table. Sounds typical, right?The only difference here is that everyone must eat several pieces of fresh fruit for dinner. No vegetables (those come on a different night) and no drinks besides water. Just fruit.Amazingly, the kids in this family acclimated to the one-fruit-night pretty fast, and now they actually enjoy it. I thought it was a rather unique way to express the importance of fresh fruits on one's diet. After all, many believe that blueberries are one of the most potent anti-cancer foods there is. Why not get in the habit of ... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=833389 Fri, 31 Aug 2007 04:00:00 +0100 833389 http://www.medworm.com/index.php?rid=828564&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F149483563%2F Chemotherapy platinum drugs including cisplatin and paraplatin are mainstay treatment for ovarian cancer. But ovarian cancer cells often fall resistant to platinum therapy which pose a problem to the treatment that even increasing the dosage is of no good because it will cause unwanted side-effects such as nerve damage and kidney failure. According to the Centers for Disease Control and Prevention, ovarian cancer is the seventh most common cancer and the fifth leading cause of cancer death among women in the United States. Now, cell culture studies of human ovarian cancer cells that are resistant to platinum drugs have been found to become 6 times more sensitized to the drugs after exposure to the cranberry compounds obtained from juice extracts. Paraplatin killed 6 times more cancer cells... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=828564 Wed, 29 Aug 2007 04:01:59 +0100 828564 http://www.medworm.com/index.php?rid=825742&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F146754161%2F Coffee addict. That’s me. I cannot start the day without coffee and I cannot go on with my day without having more coffee somewhere in between. I need the perk that the caffeine in coffee provides. I cannot remember exactly when I started drinking coffee. But I guess it must be early in my teens, because I am one of those that gave up drinking milk early. Anyway, I can live with the perk the whole day, but at night time I need something to calm me down. I dare not drink coffee beyond 5 pm, otherwise, I will be awake the whole night. So, to calm me down, I usually drink (cups of) tea after dinner. Tea has that soothing effect for me, especially green tea. We have read and heard so many health benefits from green tea already. It’s anti-heart disease benefits and most importantly, green t... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=825742 Wed, 22 Aug 2007 02:52:15 +0100 825742 http://www.medworm.com/index.php?rid=825743&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F146032689%2F Tumor cells that lack the regulatory gene p53 can be killed by the widely-prescribed diabetes drug Metformin- according to researchers at the University of Pennsylvania School of Medicine. According to senior author Craig B. Thompson, MD, Director of the Abramson Cancer Center and Chairman and Professor of Cancer Biology and Medicine: “This is the first time you can show that tumor growth is impaired by a diabetes drug. It is specific for tumors that lack p53, which is the most common mutation in human cancer.” p53 is best known as a regulator of cell division and a tumor supressor protein. Apparently, more than half of all human cancers have lost the p53 gene – making molecularly targeted therapies practically useless because there is nothing to target. Significantly, the regulation... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=825743 Mon, 20 Aug 2007 08:06:48 +0100 825743 http://www.medworm.com/index.php?rid=825745&cid=t_143337_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F144372243%2F A glass of 100 percent grape juice made from deep purple Concord grapes may provide protection against breast cancer. Natural compounds (anthocyanins) in Concord grape juice have been found to protect healthy human breast cells from DNA damage. According to Dr. Keith Singletary, nutrition professor and lead researcher at the University of Illinois: “The purple grape compounds demonstrated the capacity to inhibit DNA adduct formation as well as to increase the activity of enzymes that metabolize and detoxify carcinogens, and suppress potentially cancer-causing oxidative stress. These new data suggest that anthocyanins present in Concord grape juice, as well as some other fruits and juices, warrant further study for their breast cancer chemopreventive potential.” Also - much like red win... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=825745 Wed, 15 Aug 2007 12:00:38 +0100 825745 http://www.medworm.com/index.php?rid=658835&cid=t_143337_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F05%2Fliver-cancer-patients-see-treatment-from-kidney-cancer-drug%2F Filed under: Drug, All CancersLiver cancer is one of the toughest cancers to battle, and it claims close to half a million people each year as sufferers. Some positive news on the liver cancer front was discovered recently, as cancer specialists said that the drug sorafenib was seen to give liver cancer patients long lifespans compared to study participants who took dummy pills at the same time. The survival rates were 10.7 months and 8 months, respectively.What does this say? Well, there is more hope for liver cancer sufferers than before, although this study did not have what many would consider to be earth-shattering results. The big news here is that this is the first time something (anything) has been seen to give liver cancer patients any kind of survival advantage. That, in itself, ... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=658835 Tue, 05 Jun 2007 04:00:00 +0100 658835 http://www.medworm.com/index.php?rid=579293&cid=t_143337_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F04%2F30%2Ftoenail-fungal-drug-can-block-angiogenesis%2F Filed under: Drug, All Cancers, Research, Daily newsResearchers at Johns Hopkins discovered that a drug commonly used to treat toenail fungus could block angiogenesis, blood vessels that feed a tumor. The drug, itraconazole, is FDA approved for human use, which may fast-track its availability as an anti-cancer drug. If you are interested in reading more about Angiogenesis and cancer growth you can read my post back in July. The researchers at this point have yet to determine exactly how itraconazole works to stop vessel growth. Read | Permalink | Email this | Linking Blogs | Comments (Source: The Cancer Blog) The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=579293 Mon, 30 Apr 2007 04:00:00 +0100 579293 http://www.medworm.com/index.php?rid=579292&cid=t_143337_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F04%2F30%2Fstudy-finds-receptor-responsible-for-herceptins-poor-anticancer%2F Filed under: Breast Cancer, Drug, Research, Daily news, Cancer SurvivorsTwenty to thirty percent of breast cancers over express a protein referred to as the human epidermal growth factor receptor, better known as HER2 over expression. Herceptin is an agent that is targeted against the HER2 receptor and helps to slow or stop the spread of cancer cells that over express this protein. Unfortunately, some women that do have the over expression of HER2 on their breast cancer cells do not respond to treatment with Herceptin. The Journal of the National Cancer Institute has published a report that says among breast cancer patients with HER2 over expressing cancer cells, those whose cells also express a receptor called p95HER2 have a poor anti-cancer response rate with Herceptin. The study include... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=579292 Mon, 30 Apr 2007 04:00:00 +0100 579292